封面
市场调查报告书
商品编码
1677994

生育补充剂市场规模、份额及成长分析(按成分类型、产品、分销管道、最终用户和地区)-2025-2032 年产业预测

Fertility Supplements Market Size, Share, and Growth Analysis, By Ingredient Type (Natural, Synthetic), By Product (Capsules, Tablets), By Distribution Channel, By End User, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 198 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2023 年生育补充剂市场规模价值 21 亿美元,预计将从 2024 年的 22.6 亿美元增长到 2032 年的 40.9 亿美元,预测期内(2025-2032 年)的复合年增长率为 7.7%。

由于不孕症的上升以及人们对增强生殖功能的膳食补充剂的认识不断提高,生育补充剂市场预计将会成长。它在商店中的供应进一步推动了这种需求。然而,缺乏法律规范、产品品质不一致和高成本等挑战可能会阻碍其普及。此外,对支持这些补充剂有效性的科学证据的怀疑以及围绕不孕症的耻辱感可能会限制市场成长。相反,电子商务的日益普及和个人化营养趋势为创新和产品多样化提供了新的机会。随着越来越多的人寻求替代方法来改善他们的生殖功能,全球生育补充剂市场预计将成长,但须解决监管和品质问题以确保安全性和有效性。

目录

介绍

  • 调查目的
  • 研究范围
  • 定义

调查方法

  • 资讯采购
  • 二次资料和一次资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分机会分析

市场动态与展望

  • 市场概览
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特的分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 市场吸引力指数(2024年)
  • PESTEL分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 监管格局
  • 案例研究
  • 技术进步

生育补充品市场规模(按成分类型和复合年增长率) (2025-2032)

  • 市场概览
  • 自然的
  • 合成

生育补充品市场规模(按产品和复合年增长率) (2025-2032)

  • 市场概览
  • 胶囊
  • 药片
  • 软胶囊
  • 粉末
  • 液体

生育补充剂市场规模(按分销管道和复合年增长率) (2025-2032)

  • 市场概览
  • 在商店
  • 处方

生育补充品市场规模(按最终用户和复合年增长率) (2025-2032)

  • 市场概览
  • 男性
  • 女士

生育补充品市场规模(按地区)及复合年增长率(2025-2032)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业市场定位(2024年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市场占有率分析(2024年)
  • 主要企业简介
    • 公司详情
    • 产品系列分析
    • 公司分部份额分析
    • 收益与前一年同期比较对比(2022-2024 年)

主要企业简介

  • Fairhaven Health(USA)
  • Coast Science(USA)
  • Lenus Pharma GesmbH(Austria)
  • Active Bio Life Science GmbH(Germany)
  • Orthomol(Germany)
  • Exeltis USA, Inc.(USA)
  • Bionova(India)
  • Fertility Nutraceuticals LLC(USA)
  • Vitabiotics Ltd.(UK)
  • Extreme V, Inc.(USA)
  • Xena Bio Herbals Pvt. Ltd.(India)
  • Gonadosan Distribution GmbH(Fertilovit)(Austria)
  • InnovaMed Ltd.(Amino Expert)(UK)
  • Babystart Ltd.(UK)
  • Crown Nutraceuticals(USA)
  • Sal Nature LLC(USA)
  • Yadtech(Israel)
  • Prega News(India)
  • PlusPlus Lifesciences LLP(India)

结论和建议

简介目录
Product Code: SQMIG30I2247

Fertility Supplements Market size was valued at USD 2.1 billion in 2023 and is poised to grow from USD 2.26 billion in 2024 to USD 4.09 billion by 2032, growing at a CAGR of 7.7% during the forecast period (2025-2032).

The fertility supplements market is poised for growth, driven by rising infertility rates and increased awareness of dietary supplements for reproductive health enhancement. Over-the-counter availability further fuels this demand. However, challenges such as a lack of regulatory oversight, inconsistent product quality, and high costs may hinder accessibility. Additionally, skepticism surrounding the scientific evidence supporting the efficacy of these supplements and the stigma associated with infertility can restrain market expansion. Conversely, the growing use of e-commerce and the trend toward personalized nutrition present new opportunities for innovation and product variety. As more individuals seek alternative approaches to improve reproductive health, the global fertility supplements market is expected to grow, contingent on addressing regulatory and quality concerns to ensure safety and effectiveness.

Top-down and bottom-up approaches were used to estimate and validate the size of the Fertility Supplements market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Fertility Supplements Market Segments Analysis

Global Fertility Supplements Market is segmented by Ingredient Type, Product, Distribution Channel, End User and region. Based on Ingredient Type, the market is segmented into Natural and Synthetic. Based on Product, the market is segmented into Capsules, Tablets, Soft gels, Powders and Liquids. Based on Distribution Channel, the market is segmented into OTC and Prescribed. Based on End User, the market is segmented into Men and Women. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Fertility Supplements Market

The fertility supplements market is driven by the increasing recognition of their role in enhancing hormonal balance, stimulating ovulation, and boosting the chances of conception and childbirth for both men and women. Infertility can arise from various factors, including hormonal imbalances that lead to low sperm count or poor sperm motility in men. Various lifestyle factors, such as tobacco use, which impacted 22.3% of the global population in 2020, significantly contribute to fertility issues. With tobacco use causing around 8 million deaths annually, its adverse effects further amplify the demand for effective fertility supplements, highlighting their importance in addressing reproductive health challenges.

Restraints in the Fertility Supplements Market

Despite the growing popularity of fertility supplements, one significant restraint in the market is the insufficient scientific evidence substantiating their effectiveness. Numerous claims made by manufacturers often lack the backing of rigorous clinical trials or comprehensive studies, resulting in skepticism from both healthcare professionals and consumers. This absence of validated research raises concerns about the reliability and efficacy of these products, potentially hindering their acceptance in the healthcare community and limiting consumer trust. As a result, the lack of substantiated evidence may impede the growth and expansion of the fertility supplements market.

Market Trends of the Fertility Supplements Market

The fertility supplements market is witnessing a notable trend toward the increasing demand for natural and organic products. As consumers become more health-conscious, there is a significant shift away from synthetic alternatives in favor of supplements derived from natural ingredients like herbs, vitamins, and minerals. This preference is driven by perceptions of safety, fewer side effects, and a desire for holistic wellness solutions. Products like In Folic, which combines myo-inositol and folic acid, exemplify this trend, gaining popularity for their effective and naturally sourced compositions. This shift is likely to shape the future landscape of the fertility supplements market as awareness of organic options continues to rise.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Case Studies
  • Technological Advancement

Global Fertility Supplements Market Size by Ingredient Type & CAGR (2025-2032)

  • Market Overview
  • Natural
  • Synthetic

Global Fertility Supplements Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Capsules
  • Tablets
  • Soft gels
  • Powders
  • Liquids

Global Fertility Supplements Market Size by Distribution Channel & CAGR (2025-2032)

  • Market Overview
  • OTC
  • Prescribed

Global Fertility Supplements Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Men
  • Women

Global Fertility Supplements Market Size & CAGR (2025-2032)

  • North America (Ingredient Type, Product, Distribution Channel, End User)
    • US
    • Canada
  • Europe (Ingredient Type, Product, Distribution Channel, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Ingredient Type, Product, Distribution Channel, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Ingredient Type, Product, Distribution Channel, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Ingredient Type, Product, Distribution Channel, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Fairhaven Health (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Coast Science (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lenus Pharma GesmbH (Austria)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Active Bio Life Science GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Orthomol (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Exeltis USA, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bionova (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fertility Nutraceuticals LLC (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vitabiotics Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Extreme V, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Xena Bio Herbals Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gonadosan Distribution GmbH (Fertilovit) (Austria)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • InnovaMed Ltd. (Amino Expert) (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Babystart Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Crown Nutraceuticals (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sal Nature LLC (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Yadtech (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Prega News (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PlusPlus Lifesciences LLP (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations